Histopathological validation of electromechanical mapping in assessing myocardial viability in a porcine model of chronic ischemia

Experimental and Clinical Cardiology

Volumn 13, Issue 4, 2008, Pages 198-203

  Zheng, Yi ^a   Fernandes, Marlos R ^a   Silva, Guilherme V ^a   Cardoso, Cristiano O ^a   Canales, John ^a   Gahramenpour, Amir ^a   Baimbridge, Fred ^a   Cabreira Hansen, Maria da Graça ^a   Perin, Emerson C ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Cut off point; Electromechanical mapping; Infarct identification; Myocardial viability; Transmural infarct

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ELECTRODIAGNOSIS; ELECTROMECHANICAL MAPPING; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; MYOCARDIAL VIABILITY; NONHUMAN; SENSITIVITY AND SPECIFICITY; SWINE; VALIDATION STUDY;

EID: 63449122587     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Depre C, Vanoverschelde JL, Melin JA, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiot 1995;268:H1265-75.
2. Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163-9.
3. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction, of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41.
4. Udelson JE, Coleman PS, Metherall J, et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 1994;89:2552-61.
5. Perrone-Filardi P, Pace L, Prastaro M, et al. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24- hour 201Tl tomography versus dobutamine echocardiography. Circulation 1996;94:2712-9.
6. Qureshi U, Nagueh SF, Afridi I, et al. Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function. Circulation 1997;95:626-35.
7. Dakik HA, Howell JF, Lawrie GM, et al. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: Correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997;96:2892-8.
8. Bax JJ, Patton JA, Poldermans D, Elhendy A, Sandler MP. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: Cardiac applications. Semin Nucl Med 2000;30:281-98.
9. Macs A, Flameng W, Nuyts J, et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994;90:735-45.
10. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
11. Stillman AE, Wilke N, Jerosch-Herold M. Myocardial viabjlity. Radiol Clin North Am 1999;37:361-78.
12. Klein C, Nekolla SO, Bengel FM, et al. Assessment of myocanlial viability with contrast-enhanced magnetic resonance imaging; Comparison with positron emission tomography. Circulation 2002;105:162-7.
13. Hayat SA, Senior R. Contrast echocardiography for the assessment of myocardial viability. Curr Opin Cardiol 2006;21:473-8.
14. Kornowski R, Hong MK, Gepstein L, et al. Preliminary animal and clinical experiences using an electrorr,,Ichanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation 1998;98:1116-24.
15. Fuchs S, Hendel RC, Baim DS, et al. Comparison of endocardial electromechanical mapping with radionuclide perfusion imaging to assess myocardial viability and severity of myocardial ischemia in angina pectoris. Am J Cardiol 2001;87:874-80.
16. Kornowski R, Hong MK, Leon MB. Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability. Circulation 1998;98:1837-41.
17. Koch KC, vom Dahl J, Wenderdel M, et al. Myocardial viability assessment by endocardial electroanatomic mapping: Comparison with metabolic imaging and functional recovery after coronary revascularization. J Am Coll Cardiol 2001;38:91-8.
18. Callans DJ, Ren JF, Michele J, Marchlinski FE, Dillon SM. Electroanatomic left ventricular mapping in the porcine model of healed anterior myocardial infarction. Correlation with intracardiac echocardiography and pathological analysis. Circulation 1999;100:1744-50.
19. Lessick J, Hayam G, Zaretsky A, Reisner SA, Schwartz Y, Ben-Haim SA. Evaluation of inotropic changes in ventricular function by NOGA mapping: Comparison with echocardiography. J Appl Physiol 2002;93:418-26.
20. Perin EC, Silva GV, Sarmento-Leite R, et al. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: Validation by delayed-enhancement magnetic resonance imaging. Circulation 2002;106:957-61.
21. Kleiman NS, Patel NC, Allen KB, et al. Evolving revascularization approaches for myocardial ischemia. Am J Cardiol 2003;92:9N-17N.
22. Kinnaird T, Stabile E, Epstein SE, Fuchs S. Current perspectives in therapeutic myocardial angiogenesis. J Interv Cardiol 2003-16:289-97.
23. Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation 1997;95:1611-22.
24. Gepstein L, Hayam G, Shpun S, Ben-Haim SA. Hemodynamic evaluation of the heart with a nonfluoroscopic electromechanical mapping technique. Circulation 1997;96:3672-80.
25. Ben Haim SA, Osadchy D, Schuster I, Gepstein L, Hayam G, Josephson ME. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med 1996;2:1393-5.
26. Perin EC, Silva GV, Sarmento-Leite R, Vaughn WK, Fish RD, Ferguson JJ 3rd. Left ventricular electromechanical mapping: Preliminary evidence of electromechanical changes after successful coronary intervention. Am Heart J 2002;144:693-701.
27. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 2002;18:539-42.
28. Mack CA, Patel SR, Schwarz EA, et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 1998;115:168-76.
29. Tio RA, Tkebuchava T, Scheuermann TH, et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther 1999;10:2953-60.
30. Bhakta S, Greco NJ, Finney MR, et al. The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia. J Invasive Cardiol 2006;18:212-8.
31. Botker HE, Lassen JF, Hermansen F, et al. Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy. Circulation 2001;103:1631-7.
32. Fuchs S, Kornowski R, Shiran A, Pierre A, Ellahham S, Leon MB. Electromechanical characterization of myocardial hibernation in a pig model. Coron Artery Dis 1999;10:195-8.
33. Wolf T, Gepstein L, Dror U, et al. Detailed endocardial mapping accurately predicts the transmural extent of myocardial infarction. J Am Coll Cardiol 2001;37:1590-7.
34. Gepstein L, Goldin A, Lessick J, et al. Electromechanical characterization of chronic myocardial infarction in the canine coronary occlusion model. Circulation 1998;98:2055-64.
35. Fallavollita JA, Valeti U, Oza S, Canty JM Jr. Spatial heterogeneity of endocardial voltage amplitude in viable, chronically dysfunctional myocardium. Basic Res Cardiol 2004;99:212-22.
36. Ideker RE, Smith WM, Blanchard SM, et al. The assumptions of isochronal cardiac mapping. Pacing Clin Electrophysiol 1989;12:456-78.
37. Clement E. über eine neue Mwthode zur Untersuchung der Fortleitung des Erregungsvorgages im Herzen. Zeitschrift Für biologie 1912;58:110-61.
38. Samady H, Liu YH, Choi CJ, et al. Electromechanical mapping for detecting myocardial viability and ischemia in patients with severe ischemic cardiomyopathy. Am J Cardiol 2003;91:807-11.
39. Kornowski R, Hong MK, Leon MB. Direct myocardial revascularιzation in ischemic heart disease. Int J Cardiovasc Intervent 1998;1:3-9.
40. Hou D, Youssef EA, Brinton TJ, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials. Circulation 2005;112(9 Suppl):1150-6.